1Yashima Y, Ohgane T. Pharmacological profiles of mycophenolate mofetil, a new immuosuppressive agent [ J ]. Nippon Yakurigaku Zasshi,2001,117(2) :131.
2Allison AC ,Eugui EM. Mycophenolate mofetil and its mechanisms of action [ J ]. Immunopharmacology,2000,47 (2-3) :85.
4Coma D, Marina M, Facchinetti D, et al. Mycophenolate mofetil limits renal damage and prolongs life in murin lupus autoimmune disease[J]. Kindey Int,1997,51:1583.
6Alison AC, KowalskiWJ, Muller CT, et al. Mycophenolic acid and breguiher,inhibitor of puine and pyrimde synthesis, blok the glycosylation of adhesion moleculcs [ J ]. Transplant Proceed, 1993,25 (S2) :67.
2Briggs WA, Choi MJ, Scheel PJ. Follow-up on mycophenolater treatment of glomerular diseases[J]. Am J Kidney Dis, 1998,32: 898-899.
3Wu J C，Perspect Drug Discov Design，1994年，2期，185页
4胡伟新，肾脏病与透析肾移植杂志，1999年，8期，432页
5胡伟新，肾脏病与透析肾移植杂志，1998年，7期，427页
6Austin HA,Klippel JH,Balow JE,et al.Therapy of lupus nephritis.controlled trial of prednisone and cytotoxic drugs. N Engl J Med, 1986,314(10):614-619.
7Mok CC, Ho CT, Siu YP,et al.Treatment of diffuse proliferative lupus glomerulonephritis:a comparison of two cyclophospharmde-containing regimens. Am J Kidney Dis, 2001,38: 256-257.
8Barbano G,Gusmano R,Damasio B.Childhood- onset lupus nephritis:a single- center experience of pulse intravenous cyclophosphamide therapy.J Nephrol, 2002,15:123-129.
9Jonsson C,Carlsten H.Mycophenolic acid inhibits inosine 5(')monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines ,nitric oxide ,and LDH in macrophages. Cell Immunol, 2002,216: 93-95.
10Dooley MA,Chiso FO,Nachman PR,et al. Mycophenolate mofetil therapy in lupus nephritis:clinical observations.J Am Soc Nephrol, 1999,10:1-3.
